Loading
Latest filing published 20 Oct 2008 for CHEM RX CORP.
No signal scores available.
Robert R. Hinckley discloses dealings in Chem RX Corp to SEC (Form 4). We count 4 filings; the first trade dates from 24 January 2008 and the latest from 16 October 2008.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 20 October 2008, the filings show a share grant in Chem RX Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations